Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tom Wilkinson and Dave Singh.
Tom Wilkinson
Connection Strength
0.395
Dave Singh
  1. ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 31; 21(1):691.
    View in: PubMed
    Score: 0.224
  2. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies. Br J Clin Pharmacol. 2021 08; 87(8):3075-3091.
    View in: PubMed
    Score: 0.058
  3. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br J Pharmacol. 2021 02; 178(3):626-635.
    View in: PubMed
    Score: 0.057
  4. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Crit Care. 2020 07 22; 24(1):454.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.